1.7 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]

RxCUI
1011809
RxNorm name
1.7 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]
Display name
LIGNOSPAN (Injectable)
Full name
1.7 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]
Term type
SBD
Status
Active
Strength
0.01-20 mg/ml
Dose form
Cartridge 1.7 ml
Route
Injectable
Updated
2026-06-16 07:06:03

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
epinephrine0.01 MG / 1 MLepinephrineepinephrine
lidocaine hydrochloride20 MG / 1 MLlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Cartridge1649572

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
epinephrine3992
lidocaine6387

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0362-1095-600362-1095Lignospan Standard Lidocaine Hydrochloride and EpinephrineSeptodont, Inc.ANDA088390

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA0883900362-1095Lignospan Standard Lidocaine Hydrochloride and EpinephrineANDASeptodont, Inc.

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
00362109560rxnav_ndcsyes
00362905202rxnav_historical
00362905302rxnav_historical
00362909506rxnav_historical
12862109503rxnav_historical
12862109506rxnav_historical
51004109506rxnav_historical
51004109607rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f902d2b4-28fc-41b1-a9f7-0d1a63c598aaLignospan standard 2 % / 1:100,000 1.7 ML Dental CartridgeSY8LIGNOSPAN ®  (Lidocaine Hydrochloride and Epinephrine Injection, U.S.P.) LIGNOSPAN FORTE (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:50,000 Injection) LIGNOSPAN STANDARD (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:100,000 Injection) Rx only Solutions for local anesthesia in Dentistry20250320
f902d2b4-28fc-41b1-a9f7-0d1a63c598aa1.7 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]SBD8LIGNOSPAN ®  (Lidocaine Hydrochloride and Epinephrine Injection, U.S.P.) LIGNOSPAN FORTE (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:50,000 Injection) LIGNOSPAN STANDARD (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:100,000 Injection) Rx only Solutions for local anesthesia in Dentistry20250320
f902d2b4-28fc-41b1-a9f7-0d1a63c598aaLignospan standard 2 % / 1:100,000 in 1.7 mL Dental CartridgePSN8LIGNOSPAN ®  (Lidocaine Hydrochloride and Epinephrine Injection, U.S.P.) LIGNOSPAN FORTE (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:50,000 Injection) LIGNOSPAN STANDARD (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:100,000 Injection) Rx only Solutions for local anesthesia in Dentistry20250320

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f902d2b4-28fc-41b1-a9f7-0d1a63c598aaLIGNOSPAN ®  (Lidocaine Hydrochloride and Epinephrine Injection, U.S.P.) LIGNOSPAN FORTE (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:50,000 Injection) LIGNOSPAN STANDARD (Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:100,000 Injection) Rx only Solutions for local anesthesia in DentistrySeptodont, Inc. | Novocol Pharmaceutical of Canada, Inc.20250320

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4epinephrine
ATCR03AAAlpha- and beta-adrenoreceptor agonistsATC1-4epinephrine
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCB02BCLocal hemostaticsATC1-4epinephrine
ATCA01ADOther agents for local oral treatmentATC1-4epinephrine
ATCS01EASympathomimetics in glaucoma therapyATC1-4epinephrine
ATCR01AASympathomimetics, plainATC1-4epinephrine
FDASPLD002395CatecholaminesCHEMhas_chemical_structureepinephrine
FDASPLN0000175552alpha-Adrenergic AgonistEPChas_epcepinephrine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175555beta-Adrenergic AgonistEPChas_epcepinephrine
FDASPLN0000175570CatecholamineEPChas_epcepinephrine
FDASPLN0000000209Adrenergic alpha-AgonistsMOAhas_moaepinephrine
FDASPLN0000000245Adrenergic beta-AgonistsMOAhas_moaepinephrine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD004837EpinephrineCHEMhas_ingredientepinephrine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD000402Airway ObstructionDISEASEmay_treatepinephrine
MEDRTD000707AnaphylaxisDISEASEmay_treatepinephrine
MEDRTD001145Arrhythmias, CardiacDISEASEci_withepinephrine
MEDRTD001919BradycardiaDISEASEmay_treatepinephrine
MEDRTD001986Bronchial SpasmDISEASEmay_treatepinephrine
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withepinephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withepinephrine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatepinephrine
MEDRTD006323Heart ArrestDISEASEmay_treatepinephrine
MEDRTD006327Heart BlockDISEASEmay_treatepinephrine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD007022HypotensionDISEASEmay_treatepinephrine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatepinephrine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatepinephrine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatepinephrine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaepinephrine
MEDRTN0000009921Adrenergic beta1-AgonistsMOAhas_moaepinephrine
MEDRTN0000009922Adrenergic beta2-AgonistsMOAhas_moaepinephrine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008298Arterial VasoconstrictionPEhas_peepinephrine
MEDRTN0000008322BronchodilationPEhas_peepinephrine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000009944Decreased Intraocular Aqueous SecretionPEhas_peepinephrine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000009014Decreased Uterine Smooth Muscle Contraction or TonePEhas_peepinephrine
MEDRTN0000009070Hemostasis AlterationPEhas_peepinephrine
MEDRTN0000178478Increased Blood PressurePEhas_peepinephrine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000009808Positive ChronotropyPEhas_peepinephrine
MEDRTN0000009809Positive InotropyPEhas_peepinephrine
MEDRTN0000009820Pupillary DilationPEhas_peepinephrine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.01 MG/ML / 20 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESQUANTITY1.7 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESANDAANDA088390
CODESRxCUI1011809
CODESSPL_SET_IDf902d2b4-28fc-41b1-a9f7-0d1a63c598aa
NAMESPrescribable SynonymLignospan standard 2 % / 1:100,000 in 1.7 mL Dental Cartridge
NAMESRXNAV_STRLignospan standard 2 % / 1:100,000 1.7 ML Dental Cartridge
NAMESRxNorm Name1.7 ML epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]
NAMESRxNorm SynonymLignospan standard 2 % / 1:100,000 1.7 ML Dental Cartridge
NAMESTallman Synonym1.7 ML EPINEPHrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Cartridge [Lignospan]
SOURCESSourceMetathesaurus FDA Structured Product Labels